FAQ Library

FAQ Library published on May 5, 2016
Dr. Sekeres explains the odds your patient will have in responding to ESAs based on EPO and TPO levels, in addition to blood transfusions.
FAQ Library published on May 5, 2016
Dr. Sekeres discusses clinical trials as an option when available therapies have run out, as well as keeping a relationship with your patient after referral to a clinical trial.
FAQ Library published on May 5, 2016
Dr. Mikkael Sekeres discusses step-by-step the basic clinical workup for a lower-risk elderly MDS patient with anemia and explains his first and second tier of testing.
FAQ Library published on May 5, 2016
Failed agents can be used to determine a MDS patient's life expectancy, considering their age of diagnosis.
FAQ Library published on May 5, 2016
A higher risk of stroke has been seen in patients who use ESAs for chemotherapy-induced anemia. but none of these patients had myelodysplastic syndrome.
FAQ Library published on May 5, 2016
Dr. Mikkael Sekeres predicts the new WHO guidelines will add a category of classification in MDS, as well as slight name changes.
FAQ Library published on May 5, 2016
Join Dr. Mikkael Sekeres as he discusses which blood count abnormalities are associated with the greatest risk for patients with MDS.
FAQ Library published on May 5, 2016
Dr. Sekeres discusses why high-risk MDS patients use azacitidine based on the drug's response rate.
FAQ Library published on April 13, 2016
Join Dr. Garcia-Manero in this FAQ as he explains whether or not there is a role for therapy in low-risk MDS patients who are not transfusion dependent or do not have significant cytopenias.
FAQ Library published on March 9, 2016
Join Dr. Hetty Carraway as she describes factors that may trigger a dose reduction in high-risk MDS patients who are being treated with hypomethylating therapy.
Page 3 of 6
Results 21 - 30 of 57

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2017 MediCom Worldwide, Inc. All rights reserved